Search the TFS Resource Library
Search by keyword, or choose a Therapeutic Area to view all resources within that area of study.
Search by keyword, or choose a Therapeutic Area to view all resources within that area of study.
Explore the future of Real-World Evidence (RWE) in clinical research with insights on Common Data Models and OHDSI tools from TFS and IOMED.
Watch NowWhen a client asked for our help to run their Phase IIb Type 1 diabetes study, we knew our extensive diabetes expertise and experience in the proposed countries of Sweden, Spain, and the Czech Republic would be an asset.
DownloadPatient Recruitment of an international Phase III study in Prurigo Nodularis successfuly enrolled 6 weeks ahead of schedule.
DownloadExploring 2024 advancements in biotechnology’s impact on ophthalmology, including stem cell therapies, AI, and nanotechnology.
Read NowExplore a comprehensive look at rosacea, covering its causes, symptoms, diagnostic signs, and the latest treatment options.
Read NowExplore the evolving field of pharmacovigilance and drug safety, what role technology is playing, and how CROs like TFS navigate these changes.
Read NowDiscover insights from ASCO 2024, featuring novel cancer therapies, new tech, and discussions on cancer risk factors and patient disparities.
Read NowExplore the critical role of ethics committees in clinical trials, safeguarding patient safety and ensuring ethical standards. Learn how these committees uphold integrity in medical research. Dive into key responsibilities and their impact on trial outcomes.
Read NowDiscover how effective safety monitoring with the right CRO partner can result in substantial cost savings in clinical trials.
Read NowExplore ten recent and ongoing clinical trials focused on novel therapeutics for acne, highlighting the latest advancements in acne research.
Read NowDiscover how study coordinators play a critical role in ensuring the success of high-quality clinical trials and in alleviating pain points for CROs.
Read NowExplore insights into anticipating and addressing the shifts in drug safety monitoring needs and requirements throughout the year.
Read Now